Open research questions in Protease and Inhibitor Mechanisms
130 gap statements mined from Protease and Inhibitor Mechanisms papers in our 4.5M-paper local library, which holds 544 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Protease and Inhibitor Mechanisms? See the ranked Biology journals.
What the literature leaves open
The expression of TIMP-1 in feline sarcomas has not been previously studied. The role of the VEGF pathway in feline sarcomas has not been evaluated. Prior studies have not compared the expression of metalloproteinases and angiogenic factors between ISSs and NISSs.
Microenvironment of Sarcomas Associated and Not Associated with Inoculation Sites in Domestic Cats: The Role of Metalloproteinases and Angiogenic Factors · 2026 · DOIThe biological mechanisms of action of known collagen peptide fragments are not fully understood. The short half-life of peptide fragments is an obstacle in investigating their true biological potential. There is a need for creative ways to measure peptide fragments.
The challenge of off-target toxicity associated with broad-spectrum MMP inhibitors, - the difficulty of translating preclinical promise into clinical reality, - the need for improved patient stratification and biomarker-guided therapy.
Prior studies have shown that small airway dysfunction can occur in alpha-1 antitrypsin deficiency patients despite preserved spirometry. However, the sensitivity of spirometry for detecting small airway dysfunction is limited. The study aims to investigate the use of impulse oscillometry as a complementary tool for detecting small airway dysfunction.
Small airway dysfunction across alpha-1 antitrypsin deficiency genotypes with preserved spirometry · 2026 · DOIEarly detection of HCC remains challenging. The five-year survival rate of HCC patients is low. The underlying mechanisms of the interaction between CAFs and HCC cells are complex and not well understood.
CAF-derived miR-642a-3p supports migration, invasion, and EMT of hepatocellular carcinoma cells by targeting SERPINE1 · 2024 · DOIThe study highlights the need for sensitivity and replication analyses to support the association between cathepsin B levels and PD risk.
Serine protease inhibitor clade E member 1 (SERPINE1) is involved in various biological processes, but its role in promoting or suppressing tumorigenesis remains controversial.
Despite their well-established roles in OSCC, the overall clinical relevance of MMPs remains unclear.
Profiling the MMP family genes as prognostic biomarkers in oral squamous cell carcinoma: from computational discovery to clinical validation in a South Indian cohort · 2026 · DOIWhile the exact mode of the nonspecific interaction remains unclear, it accelerates protease inhibition and likely contributes to the nuclear localization observed for internalized vaspin and may allow for intracellular effects.
Vaspin identified as a DNA ‐binding serpin with functional consequences for protease inhibition · 2025 · DOIIn turn, stimulated cancer cells favor CAF invasiveness through a mechanism that remains to be identified.
The Rab25‐ ADAMTS5 axis as a previously undescribed mechanism for sensing tumor microenvironment complexity · 2025 · DOIAlthough the specific mechanisms and clinical applications of cancer matrisome have not yet been fully elucidated, recent techniques and analyses on cancer matrisomics have emphasized their biological importance in cancer progression and their clinical implications in deciding the efficacy of cancer treatment.
Experimental validation of the designed compounds is necessary to confirm their efficacy. Further optimization of the QSAR model and docking protocol may lead to improved results. Exploration of other potential targets for anticancer therapy is warranted.
QSAR and Docking Based Screeningof Pyrrolidine Derivatives as Matrix Metalloproteinase-2 Inhibitors · 2026 · DOIAmong the molecular regulators of these interactions, cysteine cathepsins and legumain have emerged as important proteases involved in tissue remodeling, immune regulation, and tumor progression, yet their distribution and functional status across human breast cancer ecosystems remain insufficiently defined.
Single-cell and spatial profiling of cysteine cathepsins identifies tumor states relevant to antibody-drug conjugates in breast cancer · 2026 · DOILegumain (AEP) is a cysteine protease with a highly conserved catalytic core but variable surface features whose evolutionary and structural diversity remain incompletely understood.
Several limitations of this study warrant consideration. Another limitation of this study is the age imbalance between the benign and malignant groups, which may represent a potential confounding factor influencing TIMP-1 concentrations.
Serum TIMP-1 shows a potential association with metastatic disease in patients with pancreatic cancer: a pilot analysis without a healthy control cohort · 2026 · DOISeveral cell-based studies investigating HAI-2 as a regulator of TMPRSS2 protease activity in the context of cancer and viral infections, but translation efforts with soluble HAI-2-based therapeutic strategies have not been explored yet.
Hepatocyte growth factor activator inhibitor-2 rapidly inactivates airway-expressed human Type II Transmembrane Serine Proteases · 2026 · DOIThe clinical implications of this deficiency are not yet fully understood, especially in heterozygotic individuals. Underdiagnosis is likely to be a major limitation in the study of the disease impact in the pediatric age group12. However, data regarding the pediatric population are still scarce.
Alpha-1-antitrypsin deficiency in children: a 10-year case study from a tertiary hospital · 2026 · DOILike several other MMPs, MMP13 has been shown to interact with heparan sulfate (HS), a highly sulfated glycosaminoglycan found at the cell surface and in the extracellular matrix, but the significance of the interaction remains unknown.
Heparan sulfate selectively inhibits the collagenase activity of matrix metalloproteinase 13 · 2026 · DOIArtesunate (ART), an antimalarial drug, has demonstrated anticancer properties; yet, the underlying mechanisms of its action in NPC are poorly defined.
The study did not examine the effects of FGFR-2 activation in neoplastic cells, - No studies in the available literature have examined TIMP-1 expression in feline sarcomas or TIMP-2 expression in NISS, - The chi-square test is invalid due to expected frequencies in several cells being less…
Microenvironment of Sarcomas Associated and Not Associated with Inoculation Sites in Domestic Cats: The Role of Metalloproteinases and Angiogenic Factors · 2026 · DOIInvestigation of selective MMP inhibitors beyond oncology - Development of highly selective compounds designed to preserve therapeutic efficacy while minimizing off-target toxicity - Identification of disease-and tissue-specific MMP isoforms, together with proteomic characterization of substrate…
Further studies are needed to confirm the findings, - Studies with larger sample sizes and multiple centers are required, - Research on the long-term implications of SAD in AATD patients…
Small airway dysfunction across alpha-1 antitrypsin deficiency genotypes with preserved spirometry · 2026 · DOIAnalysis of additional hinge markers may be needed to understand the extent of this phenomenon, - The study only examined the role of Mmp1 and Scaf in IR-induced fate change and translocation, - The study did not investigate the role of other extracellular proteins in IR-induced fate change…
Matrix Metalloprotease 1 (Mmp1) promotes cell fate change for epithelial-to-epithelial transition during regeneration after radiation damage in Drosophila · 2026 · DOIInvestigate the role of other extracellular proteins in IR-induced fate change and translocation, - Examine the role of Mmp1 and Scaf in other types of tissue regeneration, - Study the molecular mechanisms underlying the induction of Mmp1 and Scaf by JNK…
Matrix Metalloprotease 1 (Mmp1) promotes cell fate change for epithelial-to-epithelial transition during regeneration after radiation damage in Drosophila · 2026 · DOIThe homogeneity of our sample population, which primarily consisted of individuals of European ancestry, may have limited the generalizability of our results - Our study not observing colocalization between Cathepsin B and PD, indicating a potential confounding effect of linkage disequilibrium between the cathepsin B pQTL and PD riskassociated variants - The consideration of tissue specificity in protein biomarker…
Most-cited papers in Protease and Inhibitor Mechanisms
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations · Science · 2002 · 2,278 citations
- Matrix Metalloproteinases: A Review · Critical Reviews in Oral Biology & Medicine · 1993 · 2,252 citations
- A matrix metalloproteinase expressed on the surface of invasive tumour cells · Nature · 1994 · 2,022 citations
- Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression · International Journal of Molecular Sciences · 2021 · 498 citations
- The Structure and Biological Features of Fibrinogen and Fibrin · Annals of the New York Academy of Sciences · 2001 · 497 citations
- Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis · International Journal of Molecular Sciences · 2021 · 422 citations
- Multifunctional intracellular matrix metalloproteinases: implications in disease · FEBS Journal · 2021 · 362 citations
- The Family of Matrix Metalloproteinasesa · Annals of the New York Academy of Sciences · 1994 · 330 citations
- Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation · Frontiers in Immunology · 2021 · 230 citations
- Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic Lesionsa · Annals of the New York Academy of Sciences · 1994 · 202 citations
Most recent work
- Peptide-responsive photonic hydrogels integrated with deep learning assistance for early MMP-9 detection · Biosensors and Bioelectronics · 2026
- The role of suPAR and related proteins in kidney, heart diseases, and diabetes · Journal of Clinical Investigation · 2026
- Assembly and remodeling of collagen and elastic fibers in pathophysiology: Proteases have the final cut · FEBS Journal · 2026
- Plasma proteomics and incident coronary heart disease · Communications Medicine · 2026
- Advances in the use of MT1-MMP-targeted nanobodies and peptides for therapeutic delivery in triple-negative breast cancer · Biomedicine & Pharmacotherapy · 2026
- Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency · Hepatology · 2026
- Targeting the microbiota‐ miRNA ‐protease axis: A new therapeutic avenue in melanoma · FEBS Journal · 2026
- Proteolysis at the extracellular matrix interface: Molecular architects and regulators in health and disease · FEBS Journal · 2026
- A guide to selecting high-performing antibodies for Alpha-1-antitrypsin (UniProt ID: P01009) for use in western blot, immunoprecipitation and flow cytometry · F1000Research · 2026
- Identification of rare missense variants reducing cathepsin O secretion in families with intracranial aneurysm · Cardiovascular Research · 2026
Find a gap in your own Protease and Inhibitor Mechanisms sub-topic
This page shows what the Protease and Inhibitor Mechanisms literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →